Indications |
Ophthalmic Ocular infections Adult: As sodium: Apply 10-30% eye drops or 10% ointment into the affected eye/s. May be used up to tid. |
Contraindications |
Hypersensitivity; infants <2 mth. |
Warnings / Precautions |
Elderly. History of allergy or asthma; G6PD deficiency; renal and hepatic impairment. Prolonged therapy requires CBC and urinalysis with microscopic examination. Maintain adequate fluid intake. Pregnancy, lactation. |
Adverse Reactions |
Hypersensitivity skin reaction. Ophthalmic: Burning, stinging, conjunctivitis, corneal ulcers, irritation, conjunctival hyperaemia. Systemic absorption from inflamed conjunctiva. Potentially Fatal: Stevens-Johnson syndrome. |
Drug Interactions |
Action antagonised by PABA and procaine group of local anaesthetics. PABA present in purulent eye exudates can competitively inhibit the action of sulphacetamide. See Below for More sulfacetamide Drug Interactions |
Lab Interactions |
May interfere with diagnostic tests e.g. urinary glucose, urobilinogen, urea and creatinine. |
Mechanism of Actions |
Sulfacetamide has bacteriostatic effect on a wide range of gram-positive and gram-negative organisms. It interferes with nucleic acid synthesis thus blocking conversion of PABA to the coenzyme dihydrofolic acid. Absorption: Penetrates into ocular tissues and fluids (ophthalmic). Excretion: Urine (as unchanged drug); 7-13 hr (elimination half-life). |
Storage Conditions |
Ophthalmic: Store below 25°C. |
ATC Classification |
S01AB04 - sulfacetamide ; Belongs to the class of antiinfectives, sulfonamides. Used in the treatment of eye infections. |
Storage |
Ophthalmic: Store below 25°C. |
Available As |
|
Sulphacetamide Sodium
Post Review about Sulphacetamide Sodium Click here to cancel reply.
Sulphacetamide Sodium Containing Brands
Sulphacetamide Sodium is used in following diseases
Drug - Drug Interactions of Sulphacetamide Sodium
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.